| 產(chǎn)品編號 | bs-2001P |
| 英文名稱 | H1N1 HA Antibody Blocking Peptide |
| 中文名稱 | 甲型流感病毒血凝素封閉多肽 |
| 別 名 | HA; HA1; Hemagglutinin; Influenza A Virus [A/California/04/2009(H1N1)]. |
| 性 狀 | Lyophilized powder |
| 物 種 | [A/California/04/2009(H1N1)] |
| 純化方法 | HPLC |
| 活性 | Not tested |
| 保存條件 | Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 產(chǎn)品介紹 | bs-2001P is one synthetic peptide derived from Influenza A Virus Hemagglutinin. Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability. SWISS: P03452 Gene ID: 23308115 |
我要詢價
*聯(lián)系方式：
(可以是QQ、MSN、電子郵箱、電話等，您的聯(lián)系方式不會被公開)
*內(nèi)容：
